Cryo-Shocked platelet coupled with ros-responsive nanomedicine for targeted treatment of thromboembolic disease

X Quan, X Liang, Y Ding, Y Han, J Li, M Yuan, Y Li… - ACS …, 2023 - ACS Publications
Thrombolysis with tissue plasminogen activator (tPA) provides the most common therapy for
ischemic stroke onset within the past 4.5 h. However, enhanced neutrophil infiltration and …
被引用次数：13 相关文章
[PDF] um.edu.mo

[PDF][PDF] Cryo-Shocked Platelet Coupled with ROS-Responsive Nanomedicine for Targeted Treatment of Thromboembolic Disease

2023 - repository.um.edu.mo
Thrombolysis with tissue plasminogen activator (tPA) provides the most common therapy for
ischemic stroke onset within the past 4.5 h. However, enhanced neutrophil infiltration and …

Cryo-Shocked Platelet Coupled with ROS-Responsive Nanomedicine for Targeted Treatment of Thromboembolic Disease

X Quan, X Liang, Y Ding, Y Han, J Li, M Yuan… - ACS …, 2023 - pubmed.ncbi.nlm.nih.gov
Thrombolysis with tissue plasminogen activator (tPA) provides the most common therapy for
ischemic stroke onset within the past 4.5 h. However, enhanced neutrophil infiltration and …